Associate Professor
University of Auckland
Director of Interventional Radiology
Auckland City Hospital
Auckland, Australia
Presenter
SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR
Presenter
SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR
Session Moderator
SESSION 35: RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE PLINIO ROSSI AND LINC COMPONENTS
Presenter
SESSION 33: A) PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM; B) DR. CYNAMON'S GAME CHANGING INNOVATIONS
Presenter
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, DCBS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
Presenter
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, DCBS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
Presenter
SESSION 61: NEW OR IMPROVED ENDOVASCULAR DEVICE COMBINATIONS FOR LOWER EXTREMITY AND COMPLEX TEVAR TREATMENTS: ANGIOPLASTY BALLOON IMPROVEMENTS
Presenter
SESSION 63: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR
New Endovascular Technology (Nectero — Intra-Sac Drug After AAA Balloon Isolation) To Slow AAA Growth: Updated Clinical Results Of The First-In-Human (FIH) Trial And The stAAAble RCT
2:00 PM - 2:05 PM
Presenter
SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR
Comparison Of Long-Term Survival After Open And Endo AAA Repairs: Does It Help To Build A Case For Raising The Size Threshold For AAA Repair
2:12 PM - 2:17 PM
Session Moderator
SESSION 35: RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE PLINIO ROSSI AND LINC COMPONENTS
Presenter
SESSION 33: A) PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM; B) DR. CYNAMON'S GAME CHANGING INNOVATIONS
Active AAA Sac Management With Shape Memory Polymers: They Can Be Placed Prophylactically Or To Treat Endoleaks And Improve Outcomes After EVAR: Technique And Updated Results (From The shAAApe Trial)
10:06 AM - 10:11 AM
Presenter
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, DCBS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
Long-Term Comparative Data For The Gore VBX Balloon Expandable Covered Stents (vs. Bare Metal Stents) To Treat Iliac Occlusive Disease: Advantages And Limitations Of VBX: From The FORWARD RCT
2:12 PM - 2:17 PM
Presenter
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, DCBS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
Early Experience With A New Bioresorbable Stent Scaffold (Efemoral From Efemoral Medical) To Treat Fem-Pop Disease
2:36 PM - 2:41 PM
Presenter
SESSION 61: NEW OR IMPROVED ENDOVASCULAR DEVICE COMBINATIONS FOR LOWER EXTREMITY AND COMPLEX TEVAR TREATMENTS: ANGIOPLASTY BALLOON IMPROVEMENTS
Intravascular Lithotripsy (IVL) In Tibial Arteries: Updates From The Shockwave BTK II And Javelin Trials: New Technology Is Available
3:18 PM - 3:23 PM
Presenter
SESSION 63: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
Fluidx: A New Liquid Embolic Agent - What Makes It Different, Indication, Advantages And Precautions
5:37 PM - 5:42 PM